Testing for cytokine targeting

screening for drugs targeting Interleukin-17A (Il-17A) using human fibroblasts that release IL-6 upon IL-17A treatment

application: identification of drugs that directly block the action of cytokines as new treatment option for various inflammatory and autoimmune diseases including psoriasis